CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 33 enrolled
Drug / intervention
IOK Killing Treatment +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01605799
NCT01605799Phase 2Completed

A Novel PTSD Treatment for Veterans Who Killed in War

VA Office of Research and Development·interventional·Posted May 25, 2012·Updated Feb 23, 2016

In Brief

A Phase 2 clinical trial evaluating IOK Killing Treatment and Wait list control group for Posttraumatic Stress Disorder. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The goals of this project are * 1\) to evaluate the effectiveness of a CBT treatment module addressing the mental health and functional impact of killing in the war zone, * 2\) to gather data on Veteran stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to further refine the intervention, and * 3\) to gather data on clinician stakeholders' perceptions of acceptability and feasibility of the CBT treatment module, which would be used to ensure that the module could be easily integrated into EBT for PTSD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 25, 2012
Enrollment StartOct 1, 2012
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.1 years ago

Interventions

IOK Killing Treatmentbehavioral

The IOK Killing Treatment is based on Cognitive Behavioral Therapy theory and principals and target maladaptive cognitions related to killing in war.

Wait list control groupbehavioral

Participants in this group will not receive treatment; however, at the end of 6 weeks, they will be offered the option of receiving treatment.